OpGen, Inc. is a precision medicine company, which engages in the development of molecular information products and services to combat infectious disease in global healthcare settings, helping to guide clinicians with rapid information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
